To determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a ...

Cancer has a high death rate with delayed diagnosis of the disease being one of the main reasons for its fatality. Early ...

A new risk score model for hepatocellular carcinoma using standard clinical data can better identify individuals at risk ...

Researchers from the Walter and Eliza Hall Institute (WEHI)in Australia have found a new way to predict a subset of patients ...

A new collaboration between Home Base, Mass General, and John Hancock aims to enhance cancer detection in veterans, a group ...

Today, John Hancock, a unit of Toronto-based Manulife, announced it is providing free access to Galleri®, GRAIL's multi-cancer early detection (MCED) test, to special operations veterans receiving ...

Caris Life Sciences has obtained an FDA approval for its MI Cancer Seek tumor profiling assay, unlocking its use as a ...

Grail Inc ( (GRAL) ) has released its Q3 earnings. Here is a breakdown of the information Grail Inc presented to its investors. Grail Inc. is a ...

These miniature immune system models -- known as human immune organoids -- mimic the real-life environment where immune cells learn to recognize and attack harmful invaders and respond to vaccines.

(WISH) — In 2023, around 2 million people were told they have cancer; 610,000 of them died due to it. Now what’s being ...

After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer ...